Emodin-phospholipid complex: A potential of herbal drug in the novel drug delivery system

Journal of Thermal Analysis and Calorimetry

Volumn 108, Issue 1, 2012, Pages 289-298

  Singh, Devendra ^a   Rawat, M S M ^a   Semalty, Ajay ^a   Semalty, Mona ^a  

^a H N B GARHWAL UNIVERSITY   (India)

Author keywords

Anti cancer herbal drug; Chemical interaction; DSC; Emodin; Phospholipid complex; XR PD

Indexed keywords

CHEMICAL INTERACTION; DSC; EMODIN; HERBAL DRUG; XR-PD;

BIOCHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG DELIVERY; PHOSPHOLIPIDS; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; SPECTROSCOPIC ANALYSIS; SURFACE MORPHOLOGY; THERMOANALYSIS;

DRUG INTERACTIONS;

EID: 84858078715     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10973-011-1759-3     Document Type: Article

References (48)

1. SO Mueller M Schmitt W Dekant H Stopper J Schlatter P Schreier WK Lutz 1999 Occurrence of emodin, crysophanol and physcion in vegetables, herbs and liquors, genotoxicity and anti-genotoxicity of the anthraquinones and of the whole plant Food Chem Toxicol 37 481 491 10.1016/S0278-6915(99)00027-7 1:CAS:528:DyaK1MXltVChu7s%3D (Pubitemid 29306913)
2. D Fratta S Simi G Rainaldi PG Gervasi 1994 Role of cytochrome p-450 isoenzymes in the bioactivation of hydroxy anthraquinones Anticancer Res 14 2597 2603 1:CAS:528:DyaK2MXltlejtLY%3D
3. J Gu X Zhang Z Fei A Wen S Qin S Yi Y Chen X Li 2000 Rhubarb extracts in treating complication of severe cerebral injury Chin Med J 113 529 531 1:STN:280:DC%2BD38%2FkslOltg%3D%3D
4. LY Huang JD Hu XJ Chen LF Zhu HL Hu 2005 Effect of emodin on the proliferation inhibition and apoptosis inactivation in HL-60 cells and the involvement of c-myc gene Zhonghua Xue Ye Xue Za Zhi 26 348 351 1:CAS:528:DC%2BD28XntFCisbk%3D
5. R Liu J Zhang M Liang W Zhang S Yan M Lin 2007 Simultaneous analysis of eight bioactive compounds in danning tablet by HPLC-ESI-MS and HPLC-UV J Pharm Biomed Anal 43 1007 1012 10.1016/j.jpba.2006.09.031 1:CAS:528: DC%2BD2sXht1Oltr8%3D (Pubitemid 46185812)
6. H Yim YH Lee CH Lee SK Lee 1999 Emodin an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor Planta Med 65 1 9 13 10.1055/s-1999-13953 1:CAS:528:DyaK1MXhsVSjsbo%3D (Pubitemid 29077420)
7. CC Lin CH Chang JJ Yang T Namba M Hattory 1996 Hepatoprotective effect of emodin from Ventilago leiocarpa J Ethnopharmacol 52 2 107 111 10.1016/0378-8741(96)01397-9 1:CAS:528:DyaK28XjsVerurk%3D (Pubitemid 26137618)
8. XM Wang Y Ren 2009 Rheum tanguticum, an endangered medicinal plant endemic to China J Med Plants Res 3 13 1195 1203 1:CAS:528: DC%2BC3cXntV2nug%3D%3D
9. M Koyama TR Kelly KA Watanabe 1988 Novel type of potential anticancer agents derived from crysophanol and emodin J Med Chem 31 283 284 10.1021/jm00397a002 1:CAS:528:DyaL1cXlsFOmtg%3D%3D
10. L Zhang MC Hung 1996 Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin Oncogene 12 571 576 1:CAS:528:DyaK28XhtFCmsLw%3D (Pubitemid 26059652)
11. L Zhang CJ Chang SS Bacus MC Hung 1995 Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin Cancer Res 55 3890 3896 1:CAS:528:DyaK2MXnvVelt78%3D
12. L Zhang YK Lau L Xi RL Hong DS Kim CF Chen GN Hortobagyi CJ Chang MC Hung 1998 Tyrosine kinase inhibitor, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties Oncogene 16 2855 2863 10.1038/sj.onc.1201813 1:CAS:528:DyaK1cXjvV2ktLk%3D (Pubitemid 28383270)
13. RJ Sydiskis DG Owen JL Lohr KH Rosler RN Blomster 1991 Inactivation of enveloped viruses by anthraquinones extracted from plants Antimicrob Agents Chemother 35 2463 2466 1:CAS:528:DyaK38Xjslynsg%3D%3D
14. XM Zhou QH Chen 1988 Biochemical study of Chinese rhubarb XXII. Inhibitory effect of anthraquinone derivatives on sodium-potassium-ATPase of a rabbit renal medulla and their diuretic action Acta Pharm Sin 23 17 20 1:CAS:528:DyaL1cXitFKjt7s%3D
15. HC Huang SH Chu PD Chao-Lee 1991 Vasorelaxants from Chinese herbs, emodin and scoparone, possess immuno-suppressive properties Eur J Pharmacol 198 211 213 10.1016/0014-2999(91)90624-Y 1:CAS:528:DyaK3MXks1ChtLY%3D
16. H Fujimoto Y Satoh K Yamaguchi M Yamazaki 1998 Manoamine oxidase inhibitory constituents from Anixiella micropertusa Chem Pharm Bull 46 1506 1510 10.1248/cpb.46.1506 1:CAS:528:DyaK1cXntVSltr0%3D (Pubitemid 28531006)
17. LD Kong HKC Christopher RX Tan 2004 Inhibition of MAO A and B by some plant derived alkaloids, phenols and anthraquinones J Ethnopharmacol 91 2-3 351 355 10.1016/j.jep.2004.01.013 1:CAS:528:DC%2BD2cXjs1aqsbo%3D (Pubitemid 38561134)
18. H Jayasuriya NM Koonchanok RL Geahlen JL McLaughlin CJ Chang 1992 Emodin a Protein tyrosin kinase inhibitor from Polygonum cuspidatum J Nat Prod 55 696 698 10.1021/np50083a026 1:CAS:528:DyaK38XisVOqs70%3D
19. A Kumar S Dhawan BB Aggarwal 1998 Emodin (3-methyl-1,6,8-trihydroxy- anthraquinone) inhibits TNF-induced NF-kB activation, IkB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells Oncogene 17 913 918 10.1038/sj.onc.1201998 1:CAS:528:DyaK1cXlslGgtr8%3D (Pubitemid 28430214)
20. T Ma QH Qi J Xu ZL Dong WX Yang 2004 Signal pathways involved in emodin-induced contraction of smooth muscle cells from rat colon World J Gastroenterol 10 1476 1479 1:CAS:528:DC%2BD2cXns1Sisrs%3D (Pubitemid 39206814)
21. S Ali MS Watson RH Osborne 2004 The stimulant cathartic, emodin, contracts the rat isolated ileum by triggering release of endogenous acetylcholine Auton Autacoid Pharmacol 24 103 105 10.1111/j.1474-8673.2004. 00321.x 1:CAS:528:DC%2BD2MXhslKktg%3D%3D (Pubitemid 39657639)
22. HC Huang CR Lee PD Chao CC Chen SH Chu 1991 Vasorelaxant effect of emodin, an anthraquinone from a Chinese herb Eur J Pharmacol 205 289 294 10.1016/0014-2999(91)90912-A 1:CAS:528:DyaK38XksVSjtrk%3D
23. Y Li J Duan T Guo W Xie S Yan B Li Y Zhou Y Chen 2009 In vivo pharmacokinetics comparisons of icariin, emodin and psoralen from Gan-kang granules and extracts of Herba Epimedii, Nepal dock root, Ficus hirta yahl J Ethnopharmacol 124 3 522 529 10.1016/j.jep.2009.05.008 1:CAS:528: DC%2BD1MXptVSitrw%3D
24. ZH Teng SY Zhou RT Yang XY Liu RW Liu X Yang HBL Zhang JY Yang DY Cao QB Mei 2007 Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry Biol Pharm Bull 30 9 1628 1633 10.1248/bpb.30.1628 1:CAS:528:DC%2BD2sXhtFelsrfL (Pubitemid 47403235)
25. W Liu L Tang L Ye Z Cai B Xia J Zhang M Hu Z Liu 2010 Species and gender differences affect the metabolism of emodin via glucuronidation AAPS J 12 3 424 436 10.1208/s12248-010-9200-6 1:CAS:528:DC%2BC3cXovVKns7c%3D
26. GH Wang QX Nie H Li C Zang BX Zhang XM Zhao 2007 Comparative study on in vitro drug-release between Tuizhang ophthalmic gel and Tuizhang oculentum Zhongguo Zhong Yao Za Zhi 32 683 687 1:CAS:528:DC%2BD1cXpt1CjsA%3D%3D
27. C Leuner J Dressmann 2002 Improving drug solubility for oral delivery using solid dispersions Eur J Pharm Biopharm 54 107 112 10.1016/S0939-6411(02) 00061-9 (Pubitemid 34919382)
28. BE Rabinow 2004 Nanosuspension in drug delivery Nat Rev Drug Discov 3 785 796 10.1038/nrd1494 1:CAS:528:DC%2BD2cXntFCns7o%3D (Pubitemid 39242830)
29. TV Nijlen K Brennan VG Mooter N Blaton R Kinget P Augustijns 2003 Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions Int J Pharm 254 173 181 10.1016/S0378-5173(03)00009-7 (Pubitemid 36298826)
30. A Nokhodchi 2005 The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts J Pharm Pharm Sci 8 18 25 1:CAS:528:DC%2BD2MXivVCgsb8%3D (Pubitemid 41528866)
31. SB Murdande MJ Pikal RM Shankar RH Bogner 2011 Aqueous solubility of crystalline and amorphous drugs: challenges in measurement Pharm Dev Technol 16 3 187 200 10.3109/10837451003774377 1:CAS:528:DC%2BC3MXlsFKntr8%3D
32. HG Duan YH Wei BX Li HY Qin XA Wu 2009 Improving the dissolution and oral bioavailability of the poorly water-soluble drug aloe-emodin by solid dispersion with polyethylene glycol 6000 Drug Develop Res 70 5 363 369 10.1002/ddr.20312 1:CAS:528:DC%2BD1MXoslOhtrg%3D
33. Aigner Z, Heinrich R, Sipos E, Farkas G, Ciurba A, Berkesi O, Szabo-Revesz P. Compatibility studies of aceclofenac with retard tablet excipients by means of thermal and FT-IR spectroscopic methods. J Therm Ana Calorim. 2010; doi: 10.1007/s1097301011051.
34. Yu PF, zheng Q, Wu B, Yang M, Wang MS, Zhang HY, Hu PY, Wu ZF. Process optimization by response surface design and characterization study on geniposide pharmacosomes. Pharm dev Technol. 2010; doi: 103109/108374502010516439.
35. FR Venema WD Weringa 1988 The interactions of phospholipid vesicles with some anti-inflammatory agents J Colloid Interf Sci 125 2 484 492 10.1016/0021-9797(88)90013-6 1:CAS:528:DyaL1cXmt1WqsLs%3D
36. ® strategy to improve the bioavailability of phytochemicals Fitoterapia 81 306 314 10.1016/j.fitote.2009.11.001 1:CAS:528:DC%2BC3cXmvVWnsbs%3D
37. A Semalty M Semalty BS Rawat D Singh MSM Rawat 2009 Pharmacosomes: the lipid based novel drug delivery system Expert Opin Drug Deliv 6 6 599 612 10.1517/17425240902967607 1:CAS:528:DC%2BD1MXnt1Sis78%3D
38. PM Kidd Ph D 1996 Phosphatidylcholine: a superior protectant against liver damage Altern Med Rev 1 4 258 274 (Pubitemid 126737426)
39. PF Yue HL Yuan H Xie XH Xiao M Yang MX Liao WF Zhu PL Cai 2008 Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo Drug Dev Ind Pharm 34 7 708 718 10.1080/03639040701842477 1:CAS:528:DC%2BD1cXosVaju7s%3D (Pubitemid 351965485)
40. X Yanyu S Yunmei C Zhipeng P Qineng 2006 The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats Int J Pharm. 307 77 82 10.1016/j.ijpharm.2005.10.001 (Pubitemid 41773254)
41. K Maiti K Mukherjee A Gantait BP Saha PK Mukherjee 2007 Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats Int J Pharm 330 1-2 155 163 10.1016/j.ijpharm. 2006.09.025 1:CAS:528:DC%2BD2sXntFSnsw%3D%3D (Pubitemid 46097368)
42. A Semalty M Semalty D Singh MSM Rawat 2010 Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery J Incl Phenom Mac Chem 67 3 253 260 10.1007/s10847-009-9705-8 1:CAS:528:DC%2BC3cXmsFSntLk%3D
43. Y Li DJ Yang SL Chen SB Chen ASC Chan 2007 Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods Pharm Res 25 563 577 10.1007/s11095-007-9418-x (Pubitemid 351357731)
44. D Singh MSM Rawat A Semalty M Semalty 2011 Gallic acid-phospholipid complex: Drug incorporation and physicochemical characterization Lett Drug Design Disc 8 3 284 291 10.2174/157018011794578240 1:CAS:528: DC%2BC3MXitVyisb4%3D
45. G Bruni C Milanese V Berbenni F Sartor M Villa A Marini 2010 Crystalline and amorphous phases of a new drug J Therm Anal Calorim 102 297 303 10.1007/s10973-009-0614-2 1:CAS:528:DC%2BC3cXhtFartLzJ
46. LM Lichtenberger ZM Wang JJ Romero C Ulloa JC Perez MN Giraud JC Barreto 1995 Non steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury Nature Med 11 154 158
47. LM Lichtenberger C Ulloa JJ Romero AL Vanous JJ Romero EJ Dial PA Illich ET Walters 1996 Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems J Pharmacol Exp Ther 277 1221 1227 1:CAS:528:DyaK28XjslGlsbc%3D
48. M Perrut J Jung F Leboeuf 2005 Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. micronization of neat particles Int J Pharm 288 3 10 10.1016/j.ijpharm.2004.09. 007 1:CAS:528:DC%2BD2cXhtFahs7%2FM (Pubitemid 39656449)